CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 187 enrolled
Drug / intervention
MOM Program home visiting +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00970853
NCT00970853Phase 3Completed
CompareCT.gov

The MOM Program Continuation - 8 Year Follow-up

Children's Hospital of Philadelphia·interventional·Posted Sep 3, 2009·Updated Apr 15, 2014

In Brief

A Phase 3 clinical trial evaluating MOM Program home visiting and Control for Child Development. Completed, enrolled 187 participants across 1 site.

Detailed Summary

Study measures will evaluate cognitive, academic, and behavioral outcomes for the children, school services received, and caregiver stress and depression. The main study outcome measures include cognitive status, school functioning, and behavior. Long-term outcomes will be studied in attempt to verify the 33 and 60 month significant differences found in school participation and behavior between the intervention and control groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChild Development
CountriesUnited States
CollaboratorsWilliam Penn Foundation

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 3, 2009
Enrollment StartMar 1, 2009
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 16.8 years ago

Interventions

MOM Program home visitingbehavioral

Mixed professional home visiting program.

Controlother

Control group will receive same assessment batteries at follow-up but did not receive the home visiting program.